Related Experiment Video
Updated: Apr 8, 2026

08:40
Production of Pseudotyped Particles to Study Highly Pathogenic Coronaviruses in a Biosafety Level 2 Setting
Published on: March 1, 2019
58.9K
Digital Twin for Continuous Production of Virus-like Particles toward Autonomous Operation
Alina Hengelbrock1, Finja Probst1, Simon Baukmann1
1Institute for Separation and Process Technology, Clausthal University of Technology, Clausthal 38678, Zellerfeld, Germany.
ACS Omega
|August 19, 2024
Summary
This study developed a digital twin for autonomous manufacturing of virus-like particles (VLPs), achieving a twofold productivity increase. The advanced process control strategy further boosted gains by 20% with high reliability.
Area of Science:
- Biopharmaceutical Manufacturing
- Process Engineering
- Digital Twins
Background:
- Previous lentiviral vector and virus-like particle (VLP) manufacturing utilized batch or fed-batch upstream and downstream processes.
- Continuous upstream processing in perfusion mode has been explored, presenting challenges in separating particles of similar sizes.
Purpose of the Study:
- To develop and validate a digital twin for autonomous manufacturing of human embryo kidney cell-based VLPs.
- To demonstrate the benefits of integrating a physical-chemical mechanistic model with process analytical technology for autonomous operation.
Main Methods:
- Model calibration of a digital twin using experimental data for VLP manufacturing.
- Integration of a Quality-by-Design (QbD) approach, including risk assessment for design and control space definition.
- Development of innovative tangential flow filtration for efficient separation of VLPs, cells, and debris in continuous perfusion mode.
Main Results:
- A twofold increase in VLP manufacturing productivity was achieved through simulation case studies.
- Application of the digital twin with advanced process control demonstrated an additional 20% productivity gain.
- The system achieved 99.9% reliability in autonomous operation.
Conclusions:
- Digital twins offer significant benefits for autonomous biopharmaceutical manufacturing, enhancing productivity and reliability.
- Innovative filtration strategies are crucial for efficient continuous processing of VLPs.
- The developed digital twin provides a validated framework for optimizing VLP production.

